Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questions
| Autor: | Maura Rossi, Manuela Alessio, Antonella Fasciolo, Gianmauro Numico, Vittorio Fusco, Iolanda De Martino |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Oncology
medicine.medical_specialty Dentistry Bone Neoplasms Bone resorption 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans 030212 general & internal medicine Bone Density Conservation Agents Diphosphonates business.industry Incidence Incidence (epidemiology) Osteonecrosis Cancer General Medicine medicine.disease Denosumab 030220 oncology & carcinogenesis Osteonecrosis of the jaw business medicine.drug |
| Zdroj: | Acta Clinica Belgica. 73:163-164 |
| ISSN: | 2295-3337 1784-3286 |
| Popis: | We read with great interest the paper by Loyson et al. reporting the ONJ (osteonecrosis of jaw) incidence in cancer patients receiving bone metastases long-term treatment with bone resorption inhib... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|